SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-022859
Filing Date
2017-04-28
Accepted
2017-04-28 09:00:38
Documents
5
Period of Report
2017-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v465350_8k.htm 8-K 32388
2 EXHIBIT 2.1 v465350_ex2-1.htm EX-2.1 808635
3 EXHIBIT 4.1 v465350_ex4-1.htm EX-4.1 151924
4 EXHIBIT 99.1 v465350_ex99-1.htm EX-99.1 13981
5 GRAPHIC image_001.jpg GRAPHIC 2576
  Complete submission text file 0001144204-17-022859.txt   1011989
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 17791838
SIC: 8731 Services-Commercial Physical & Biological Research